Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Lexicon Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- +14 vs. Q3 2021
- Shares held
- 121.6M
- +355.0K (+0.3%) vs. Q3 2021
- Total value
- $478.9M
- −$104.1M (−17.9%) vs. Q3 2021
- New holders
- 24
- 38 more added
- Sold out
- 10
- 29 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 149 | $875.1M |
| Q1 2026 | 137 | $504.5M |
| Q4 2025 | 126 | $299.5M |
| Q3 2025 | 124 | $344.4M |
| Q2 2025 | 123 | $242.9M |
| Q1 2025 | 127 | $122.5M |
| Q4 2024 | 127 | $220.1M |
| Q3 2024 | 137 | $453.1M |
| Q2 2024 | 127 | $471.0M |
| Q1 2024 | 118 | $417.8M |
| Q4 2023 | 106 | $279.8M |
| Q3 2023 | 112 | $205.8M |
| Q2 2023 | 123 | $438.2M |
| Q1 2023 | 104 | $353.8M |
| Q4 2022 | 105 | $280.5M |
| Q3 2022 | 98 | $357.3M |
| Q2 2022 | 86 | $221.0M |
| Q1 2022 | 101 | $251.3M |
| Q4 2021 | 110 | $478.9M |
| Q3 2021 | 96 | $583.0M |
| Q2 2021 | 107 | $540.2M |
| Q1 2021 | 107 | $711.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Lexicon Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 1,197,739 | $4.72M | 0.00% | +3,817+0.3% | Added |
| State Street Corp | 1,215,018 | $4.79M | 0.00% | +113,265+10.3% | Added |
| Pinnacle Associates Ltd | 2,127,662 | $8.38M | 0.14% | +30,015+1.4% | Added |
| NEA Management Company, LLC | 2,382,286 | $9.39M | 0.19% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 2,808,428 | $11.1M | 0.01% | −407,620−12.7% | Reduced |
| Vanguard Group Inc | 4,151,752 | $16.4M | 0.00% | +166,572+4.2% | Added |
| BlackRock Inc. | 4,547,924 | $17.9M | 0.00% | −102,746−2.2% | Reduced |
| FMR LLC | 5,668,138 | $22.3M | 0.00% | −793,218−12.3% | Reduced |
| BVF Inc | 14,360,000 | $56.6M | 2.05% | 00.0% | Unchanged |
| Artal Group S.A. | 71,178,364 | $280.4M | 8.24% | 00.0% | Unchanged |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0 | $0 | 0.00% | −126,917−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −46,300−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −27,978−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −13,652−100.0% | Sold out |
| Klingenstein Fields & Co LP | 0 | $0 | 0.00% | −10,618−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −1,535−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −1,415−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −1,079−100.0% | Sold out |